Mathematical modeling for prediction of secondary BRCA1 and BRCA2 mutations in ovarian cancers with deleterious germline BRCA1 and BRCA2 mutations

被引：0
|
作者：
Botesteanu, Dana-Adriana
Levy, Doron
Lee, Jung-Min
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2709
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2709
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Unwrapping the Implications of BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Hyman, David M.
    Spriggs, David R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 408 - 410
  • [32] Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer
    Ramus, Susan J.
    Harrington, Patricia A.
    Pye, Carole
    DiCioccio, Richard A.
    Cox, Mark J.
    Garlinghouse-Jones, Kim
    Oakley-Girvan, Ingrid
    Jacobs, Ian J.
    Hardy, Richard M.
    Whittemore, Alice S.
    Ponder, Bruce A. J.
    Piver, M. Steven
    Pharoah, Paul D. P.
    Gayther, Simon A.
    [J]. HUMAN MUTATION, 2007, 28 (12) : 1207 - 1215
  • [33] Screening for ovarian cancer in BRCA1/BRCA2 mutations carriers
    Synowiec, Agnieszka
    Wcislo, Gabriel
    Bodnar, Lubomir
    Gasowska-Bodnar, Agnieszka
    Szczylik, Cezary
    [J]. GINEKOLOGIA POLSKA, 2014, 85 (05) : 377 - 381
  • [34] Cancers Associated With BRCA1 and BRCA2 Mutations Other Than Breast and Ovarian
    Mersch, Jacqueline
    Jackson, Michelle A.
    Park, Minjeong
    Nebgen, Denise
    Peterson, Susan K.
    Singletary, Claire
    Arun, Banu K.
    Litton, Jennifer K.
    [J]. CANCER, 2015, 121 (02) : 269 - 275
  • [35] High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
    Al-Joharah Alhuqail
    Areej Alzahrani
    Hannah Almubarak
    Sarah Al-Qadheeb
    Lamyaa Alghofaili
    Nisreen Almoghrabi
    Hamed Alhussaini
    Ben Ho Park
    Dilek Colak
    Bedri Karakas
    [J]. Breast Cancer Research and Treatment, 2018, 168 : 695 - 702
  • [36] High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
    Alhuqail, Al-Joharah
    Alzahrani, Areej
    Almubarak, Hannah
    Al-Qadheeb, Sarah
    Alghofaili, Lamyaa
    Almoghrabi, Nisreen
    Alhussaini, Hamed
    Park, Ben Ho
    Colak, Dilek
    Karakas, Bedri
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (03) : 695 - 702
  • [37] The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population
    Song, Honglin
    Cicek, Mine S.
    Dicks, Ed
    Harrington, Patricia
    Ramus, Susan J.
    Cunningham, Julie M.
    Fridley, Brooke L.
    Tyrer, Jonathan P.
    Alsop, Jennifer
    Jimenez-Linan, Mercedes
    Gayther, Simon A.
    Goode, Ellen L.
    Pharoah, Paul D. P.
    [J]. HUMAN MOLECULAR GENETICS, 2014, 23 (17) : 4703 - 4709
  • [38] Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients Finding Founder Mutations
    Choi, Min Chul
    Heo, Jin-Hyung
    Jang, Ja-Hyun
    Jung, Sang Geun
    Park, Hyun
    Joo, Won Duk
    Lee, Chan
    Lee, Je Ho
    Lee, Jun Mo
    Hwang, Yoon Young
    Kim, Seung Jo
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (08) : 1386 - 1391
  • [39] BRCA1 and BRCA2
    Bertwistle, D
    Ashworth, A
    [J]. CURRENT BIOLOGY, 2000, 10 (16) : R582 - R582
  • [40] High Frequency of BRCA1 and BRCA2 Germline Mutations in a Series of Resected Pancreatic Adenocarcinoma and Other Preneoplastic Lesions Suggests an Association With BRCA1 and BRCA2 Mutations
    Lucas, Aimee L.
    Mitchel, Elana B.
    Hwang, Caroline
    Kumar, Sheila
    Deng, Liyong
    Shakya, Reena
    Ludwig, Thomas
    Chabot, John A.
    Chung, Wendy
    Frucht, Hatold
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S355 - S355
12345